Search research articles
Contact Us
Filters
Showing results (351-360 of 456) with videos related to
Page
of 46
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2017
Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels
Paolo G Casali, John Zalcberg, Axel Le Cesne, et al.
Insights Into Imaging
|
June 14, 2025
Diagnostic work-up of lipomatous tumors: a decision-making analysis among European sarcoma centers
Ali Naimi, Paul Martin Putora, Christian Rothermundt, et al.
The Lancet. Oncology
|
February 16, 2026
Vibostolimab coformulated with pembrolizumab versus pembrolizumab alone as adjuvant therapy for high-risk stage IIB-IV melanoma (KEYVIBE-010): a randomised, double-blind, phase 3 study
Reinhard Dummer, Jun Guo, Jason J Luke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2024
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study
Jason J Luke, Paolo A Ascierto, Muhammad A Khattak, et al.
The New England Journal of Medicine
|
January 5, 2022
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
Hussein A Tawbi, Dirk Schadendorf, Evan J Lipson, et al.
Annals of Surgical Oncology
|
June 14, 2013
Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience
Piotr Rutkowski, Alessandro Gronchi, Peter Hohenberger, et al.
JAMA Surgery
|
April 3, 2020
Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib
Alessandro Gronchi, Sylvie Bonvalot, Andres Poveda Velasco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2015
Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas
Paolo G Casali, Axel Le Cesne, Andres Poveda Velasco, et al.
Annals of Surgery
|
July 14, 2022
Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma: EORTC-62092 Trial (STRASS) Versus Off-trial (STREXIT) Results
Dario Callegaro, Chandrajit P Raut, Taiwo Ajayi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 25, 2023
Clinical, histopathological and molecular features of dedifferentiated melanomas: An EORTC Melanoma Group Retrospective Analysis
Juergen Hench, Daniela Mihic-Probst, Abbas Agaimy, et al.
Page
of 46
Search research articles
Search
Showing results (351-360 of 456) with videos related to
Sort By:
Page
of 46
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2017
Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels
Paolo G Casali, John Zalcberg, Axel Le Cesne, et al.
Insights Into Imaging
|
June 14, 2025
Diagnostic work-up of lipomatous tumors: a decision-making analysis among European sarcoma centers
Ali Naimi, Paul Martin Putora, Christian Rothermundt, et al.
The Lancet. Oncology
|
February 16, 2026
Vibostolimab coformulated with pembrolizumab versus pembrolizumab alone as adjuvant therapy for high-risk stage IIB-IV melanoma (KEYVIBE-010): a randomised, double-blind, phase 3 study
Reinhard Dummer, Jun Guo, Jason J Luke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2024
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study
Jason J Luke, Paolo A Ascierto, Muhammad A Khattak, et al.
The New England Journal of Medicine
|
January 5, 2022
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
Hussein A Tawbi, Dirk Schadendorf, Evan J Lipson, et al.
Annals of Surgical Oncology
|
June 14, 2013
Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience
Piotr Rutkowski, Alessandro Gronchi, Peter Hohenberger, et al.
JAMA Surgery
|
April 3, 2020
Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib
Alessandro Gronchi, Sylvie Bonvalot, Andres Poveda Velasco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2015
Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas
Paolo G Casali, Axel Le Cesne, Andres Poveda Velasco, et al.
Annals of Surgery
|
July 14, 2022
Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma: EORTC-62092 Trial (STRASS) Versus Off-trial (STREXIT) Results
Dario Callegaro, Chandrajit P Raut, Taiwo Ajayi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 25, 2023
Clinical, histopathological and molecular features of dedifferentiated melanomas: An EORTC Melanoma Group Retrospective Analysis
Juergen Hench, Daniela Mihic-Probst, Abbas Agaimy, et al.
Page
of 46